Edwards Lifesciences Corp (EWL): aksiya narxi va yangiliklar

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia

Edwards Lifesciences Corp haqida

CEO-

Xodimlar soni16 ming

Asos solingan1958

Bosh ofislarIrvayn, Kaliforniya, Amerika Qo‘shma Shtatlari

Sektor-

Veb-saytedwards.com

Barcha qiymatlar – USD	sen, 2025	dek, 2025	mar, 2026	iyn, 2026
Daromad	1,55 mlrd	1,57 mlrd	1,65 mlrd	1,74 mlrd
Sotilgan mahsulotning tannarxi	345,20 mln	343,00 mln	362,60 mln	392,40 mln
Daromad narxi	345,20 mln	343,00 mln	362,60 mln	392,40 mln
Tadqiqot va ishlanmalarga xarajatlar	280,70 mln	267,70 mln	263,30 mln	278,90 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar	-	-	-	-
Tijoriy, umumiy va maʼmuriy xarajatlar	514,60 mln	601,20 mln	522,20 mln	561,20 mln
Operatsion xarajatlar	782,80 mln	854,60 mln	771,30 mln	829,10 mln
Jami operatsion xarajatlar	1,13 mlrd	1,20 mlrd	1,13 mlrd	1,22 mlrd
Operatsion daromad	425,10 mln	372,00 mln	514,70 mln	519,50 mln
Boshqa nooperatsion daromad	1,10 mln	2,30 mln	69,90 mln	-25,00 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar	348,40 mln	90,40 mln	459,00 mln	519,80 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno	444,50 mln	464,00 mln	603,60 mln	511,10 mln
Daromad soligʻi boʻyicha xarajat	56,10 mln	26,20 mln	78,30 mln	278,40 mln
Amaldagi soliq stavkasi	16,10%	28,98%	17,06%	53,56%
Boshqa operatsion xarajatlar	-12,50 mln	-14,30 mln	-14,20 mln	-11,00 mln
Sof foyda	291,10 mln	91,20 mln	380,70 mln	241,90 mln
Sof foyda marjasi	18,74%	5,81%	23,09%	13,89%
Har bir aksiya foydasi	0,67	0,58	0,78	0,78
Foizlar va investitsiyalardan olingan daromadlar	16,70 mln	114,20 mln	17,40 mln	15,00 mln
Foizlarni toʻlash xarajatlari	-	-20,40 mln	-	-
Foizlarni toʻlash boʻyicha sof xarajatlar	16,70 mln	93,80 mln	17,40 mln	15,00 mln
Amortizatsiya ajratmalari	-	-	-	-
EBITDA	464,30 mln	414,70 mln	555,60 mln	562,20 mln
Aktivlarni sotishdan olingan foyda yoki zarar	-	-33,90 mln	-	-

Finance

Savol bering